Sendance
Provides soft, conformable sensor grids and a cloud data platform for smart wearables and medical devices.
Website: https://sendance.at
Cover Block
PUBLIC
| Name | Sendance |
| Tagline | Provides soft, conformable sensor grids and a cloud data platform for smart wearables and medical devices. |
| Headquarters | Linz, Austria |
| Founded | 2021 |
| Stage | Seed |
| Business Model | Hardware + Software |
| Industry | Deeptech |
| Technology | Hardware |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
| Funding Label | Seed (total disclosed ~$825,000) |
Links
PUBLIC
- Website: https://www.sendance.at
- LinkedIn: https://at.linkedin.com/company/sendance-gmbh
Data Accuracy: GREEN -- Company website and LinkedIn page confirmed via multiple sources.
Executive Summary
PUBLIC Sendance is an Austrian deep-tech startup that provides device manufacturers with a proprietary platform to embed soft, conformable sensor grids and a cloud data layer into existing orthopedic, assistive, and sports products, converting passive hardware into regulated data streams [Perplexity Sonar Pro Brief]. The company merits investor attention for its patented approach to a high-value, regulated niche: enabling manufacturers to add continuous health monitoring without developing their own sensor or cloud infrastructure, thereby accelerating time-to-market [Advantage Austria].
Founded in 2021 as a spin-off from the LIT Soft Materials Lab at Johannes Kepler University Linz, the company leverages over a decade of academic research in soft materials and stretchable electronics [Tech2b]. Its core offering, branded "Smart Product-as-a-Service," combines the physical "sendance-grid",a permeable, stretchable sensor that can be integrated into textiles, foam, or 3D-printed materials,with the "sendance-cloud" data management platform for analytics and compliance [OTWorld, 2026].
The founding team, led by CEO Robert Koeppe and CTO Yana Vereshchaga, brings direct expertise from the originating research lab, combining materials science, electronics engineering, and healthcare applications [LinkedIn, 2026]. To date, Sendance has raised capital from a mix of angel investors, venture capital firms including Garage Angels and Electron Capital Partners, and public funding programs such as EIT Health Bridgehead and an Austrian state aid grant [Trending Topics, July 2023] [Northdata, 2024]. Its business model is B2B, targeting recurring revenue from manufacturers embedding its technology.
Over the next 12-18 months, the key watchpoints are the transition from pilot projects and program participation to announced commercial deployments with named device manufacturers, and the scaling of its automated production capabilities as referenced in company materials [Medizintechnik-Cluster].
Data Accuracy: YELLOW -- Core product and team details are well-corroborated; funding totals are reported from multiple sources but with some variance.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Seed |
| Business Model | Hardware + Software |
| Industry / Vertical | Deeptech |
| Technology Type | Hardware |
| Geography | Western Europe |
| Growth Profile | Venture Scale |
| Founding Team | Academic Spinout |
| Funding | Seed (total disclosed ~$825,000) |
Company Overview
PUBLIC
Sendance GmbH was founded in March 2021 as a direct spin-off from the LIT Soft Materials Lab at Johannes Kepler University (JKU) in Linz, Austria, where its core technology was developed [Perplexity Sonar Pro Brief]. The company is headquartered in Linz, Austria, maintaining a physical presence at Pulvermühlstraße 3 [Perplexity Sonar Pro Brief]. Its founding team, emerging from academic research, includes Daniela Wirthl, Yana Vereshchaga, Robert Koeppe, and Thomas Stockinger, blending expertise in soft materials science, electronics, and business operations [LinkedIn, 2026] [Tech2b].
Key corporate milestones follow a path typical of a European deep-tech spinout. The company secured a pre-seed round in February 2023, raising $355,729 [Crunchbase, Feb 2023]. This was followed by a convertible note seed round in July 2023, led by Czech investor group Garage Angels with participation from Electron Capital Partners, described as a "six-figure" investment [Trending Topics, July 2023]. In 2024, the company received state aid of €246,980 from the Austrian Research Promotion Agency (FFG) under its SME Directive for the 2024-2026 period [Northdata, 2024]. By 2026, the team had expanded its advisory board with the addition of Tim Juergens [LinkedIn, 2026].
Data Accuracy: GREEN -- Founding, location, and funding events confirmed by multiple independent public sources (Crunchbase, LinkedIn, Trending Topics, Northdata).
Product and Technology
MIXED Sendance's core proposition is a dual-component system designed to make passive medical and sports devices data-generating assets. The company provides permeable, stretchable sensor grids, branded as 'sendance-grid,' that can be integrated into materials like textiles, foam, or 3D-printed plastics [Perplexity Sonar Pro Brief]. This hardware is paired with 'sendance-cloud,' a data management platform that handles the visualization, storage, and analysis of the captured sensor streams [Perplexity Sonar Pro Brief]. The combined offering is marketed as a 'Smart Product-as-a-Service' intended to support manufacturers from initial concept through to the operational use of the smart product by their end customers [OTWorld, 2026].
The technology's key differentiator is its physical adaptability. The patented sensor grids are described as soft and conformable, capable of being stretched and withstanding high pressure while maintaining functionality [OTWorld, 2026] [Sendance Website]. This allows them to be embedded directly into the freeform surfaces of products like orthopedic insoles, prostheses, or orthoses without compromising fit or comfort [LinkedIn, 2026]. A specific development tool, the 'sendance-glove,' functions as a 3D scanner to capture the shape and softness of a patient's body, presumably to inform custom sensor integration [LinkedIn, 2026]. On the software side, the cloud platform is built to handle data in compliance with data protection regulations, a critical requirement for health applications [OTWorld, 2026].
Public materials emphasize an iterative, customer-centric development process. The company states it works with manufacturers to develop prototypes until product maturity is reached, with automated production lines prepared for market launch [Medizintechnik-Cluster]. This suggests the business model involves close collaboration on product design and integration, rather than selling off-the-shelf sensor kits. The platform is positioned to enable use cases such as tracking the fit of a prosthetic over time as a patient's body changes, or monitoring pressure distribution for patients with neuropathy who cannot verbally communicate discomfort [Sendance Website].
Data Accuracy: GREEN -- Product claims and technical specifications are consistently described across the company website, press coverage, and industry presentation materials.
Market Research
PUBLIC
Sendance's bet is that the integration of continuous, passive sensing into everyday medical and assistive devices will unlock new forms of data-driven care, a transition currently held back by the rigidity of conventional electronics. The company's cited market opportunity rests on the convergence of two established trends: the aging global population driving demand for assistive technologies, and the ongoing digitization of healthcare delivery that values remote monitoring and preventative analytics.
The company's public materials reference a total addressable market estimated at €91 billion, growing at a compound annual rate of approximately 12.8% toward 2030 [F6S]. This figure is presented as the value of the broader assistive devices and connected health wearables market that Sendance's technology aims to serve. While the specific methodology behind this figure is not detailed in public sources, it aligns with analogous third-party analyses. For instance, Grand View Research valued the global wearable medical devices market at $27.2 billion in 2023, projecting a 26.1% CAGR through 2030 [Grand View Research, 2024], a segment that overlaps significantly with Sendance's orthopedic and monitoring focus.
Key demand drivers for this segment are well-documented in adjacent industry research. The demographic shift toward older populations in Europe and North America is a primary tailwind, increasing the prevalence of mobility issues and chronic conditions that require orthotic and prosthetic solutions. Concurrently, healthcare systems are under pressure to shift from reactive, hospital-centric care to proactive, home-based management, creating demand for devices that can generate actionable, longitudinal patient data. Regulatory frameworks like the EU's Medical Device Regulation (MDR) and digital health initiatives are also shaping the market, pushing manufacturers toward solutions that can demonstrate clinical efficacy and data security.
| Metric | Value |
|---|---|
| Assistive & Connected Health Wearables Market (cited) | 91 €B |
| Projected CAGR to 2030 (cited) | 12.8 % |
The cited market size is substantial, but it is important to distinguish the broader TAM from Sendance's specific serviceable market. The company operates in a B2B niche, selling sensor grids and a data platform to manufacturers, not finished devices to end-users. Its immediate SAM is therefore the subset of device makers in orthopedics, sports, and wound care who are actively seeking to digitize their product lines and lack in-house soft electronics expertise. The growth rate suggests a rapidly expanding pie, but penetration will depend on convincing traditionally conservative medical device OEMs to adopt a new, platform-based component supplier.
Data Accuracy: YELLOW -- The €91 billion TAM figure is cited from a single source (F6S) without independent public corroboration of the specific number. The growth trajectory and underlying demand drivers are consistent with multiple third-party market reports on digital health and wearables.
Competitive Landscape
MIXED
Sendance enters a specialized hardware-plus-software market defined by the challenge of embedding reliable sensing into soft, dynamic surfaces, a niche where traditional rigid electronics are not viable.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Sendance | B2B platform providing soft, conformable sensor grids and a cloud data layer for orthopedic, assistive, and sports device manufacturers. | Seed; €2.6 million total raised (estimated) [Dealroom.co, 2026]. | Patented soft sensor grids integrated into textiles/foam/3D prints; full-stack "Smart Product-as-a-Service" offering. | [Advantage Austria] [Sendance Website] |
The competitive map for soft sensing in healthcare and sports splits along two axes: the type of sensing (pressure, strain, motion) and the go-to-market model (component supplier versus full-stack platform). Established medical device incumbents like Tekscan and Novel GmbH offer sophisticated pressure mapping systems, but these are typically standalone diagnostic tools sold directly to clinics, not embeddable components for OEMs [PUBLIC]. Adjacent substitutes include inertial measurement unit (IMU) sensor modules from companies like Xsens or Movea, which track motion but not pressure distribution, and emerging electronic skin (e-skin) research from academic labs and larger corporations like MC10 [PUBLIC]. Sendance's primary competition likely comes from other deep-tech startups, like ReTiSense, which also develop flexible sensor systems, and from internal R&D efforts at large orthopedic and sportswear manufacturers who may seek to build proprietary sensing capabilities [PUBLIC].
Sendance's current defensible edge appears rooted in its academic spinout origin and its integrated platform approach. The team's background from the LIT Soft Materials Lab at Johannes Kepler University provides deep, patented expertise in making sensors that are permeable, stretchable, and structurally adapted, a materials science moat that is not easily replicated [Tech2b] [LinkedIn, 2026]. Furthermore, by offering not just sensors but the accompanying cloud data management and compliance layer, the company positions itself as a strategic partner that can accelerate a manufacturer's time-to-market, a claim quantified as a "factor of 6" acceleration [Advantage Austria]. This edge is durable if the company continues to out-innovate on material integration and maintains its first-mover platform advantage with early OEM partners. However, it is perishable if a competitor with greater capital or manufacturing scale achieves similar material properties and undercuts on price or service.
The company's most significant exposure is its reliance on a business-to-business (B2B) sales model targeting device manufacturers, a channel known for long development and sales cycles, especially in regulated medical fields. A competitor with a direct-to-consumer or direct-to-clinic product could build brand recognition and data scale faster, potentially bypassing OEMs entirely. Furthermore, while Sendance's technology is adaptable, its public case studies focus on orthopedic and assistive devices; it may be less optimized for high-volume, low-cost applications in consumer sportswear, where competitors focused solely on textile integration might have an advantage [PUBLIC]. The lack of publicly named customer deployments, while common for early-stage B2B hardware companies, also makes it difficult to assess real-world traction against competitors who may have announced flagship partners.
Over the next 18 months, the most plausible competitive scenario hinges on which company secures the first major, publicly referenceable partnership with a recognized medical device OEM. If Sendance can use its EIT Health network and Austrian innovation grants to land a co-development deal with a mid-sized orthopedic manufacturer, it would validate its platform approach and create a formidable case study. In that scenario, Sendance would be the winner. Conversely, if a competitor like ReTiSense, or an incumbent launching a new flexible sensing division, signs a similar deal first, it could lock up a key channel partner and absorb early adopter demand, leaving Sendance as a loser in the race for market-defining partnerships. The battleground is less about raw technology, which appears advanced, and more about commercial execution and partnership velocity.
Data Accuracy: YELLOW -- Competitor data is limited to one named entity; broader landscape analysis is based on public segment descriptions.
Opportunity
PUBLIC
If Sendance executes on its core proposition, the company could become the default infrastructure layer for generating regulated health data from physical medical and assistive devices, a role that could unlock recurring revenue from a market projected to reach €91 billion by 2030 [F6S].
The headline opportunity is for Sendance to become the category-defining B2B platform that enables any manufacturer of orthopedic, prosthetic, or sports equipment to convert a passive product into a regulated, data-generating smart device. The evidence that this outcome is reachable, rather than purely aspirational, lies in the company's patented integration of soft materials science with a full-stack cloud offering. Unlike pure sensor providers or software-only platforms, Sendance's wedge is a vertically integrated "Smart Product-as-a-Service" that handles the entire chain from conformable hardware embedding to compliant data management [Advantage Austria]. This full-stack approach directly addresses the primary barrier for device manufacturers, who lack the deep-tech expertise to build such systems internally and face long development cycles. The company's claim that its platform can accelerate a manufacturer's market entry by a factor of six, while unverified, points directly to the core value proposition that could drive adoption [Advantage Austria].
Growth from its current seed-stage position would likely follow one of several concrete, high-scale paths. The scenarios below outline plausible routes to significant market penetration.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Standardization in Orthopedic Prosthetics | Sendance's sensor grids become the de facto method for monitoring fit and load in prosthetic sockets, mandated by leading insurers or adopted by major OEMs. | A strategic partnership with a top-5 global prosthetic manufacturer to co-develop a next-gen smart product line. | The technology is specifically highlighted for tracking prosthetic fit as patient conditions change, a critical unmet need in the industry [Sendance Website]. The academic spin-out team has deep domain expertise in soft materials for health applications [Tech2b]. |
| Horizontal Expansion into Sports & Wellness | The platform is licensed by major sportswear brands for embedding in premium performance footwear and athletic gear, creating a high-volume, lower-ACV revenue stream. | A pilot deployment with a European sports brand for smart insoles used in professional athlete training. | Company materials explicitly list sports as a core vertical, and the sensor technology is described as suitable for textiles and foams common in athletic wear [Vestbee, Sendance Website]. |
| Regulatory-Driven Adoption in Pressure Ulcer Prevention | Hospital procurement guidelines begin to favor continuous pressure monitoring systems, making Sendance's sensor-integrated wound dressings or support surfaces a compliance requirement. | Successful completion of a clinical study, possibly funded through an EU Horizon or EIT Health program, demonstrating improved patient outcomes. | The company's use cases include decubitus (pressure ulcer) monitoring [Perplexity Sonar Pro Brief], and it has experience with Horizon Europe projects in the health sector, indicating a path to clinical validation [DevelopmentAid]. |
Compounding for Sendance would manifest as a classic data and design lock-in flywheel. An initial design win with a manufacturer embeds Sendance's proprietary grid architecture and cloud API into a product's blueprint. Subsequent iterations and new product lines from that manufacturer would naturally default to the same integrated platform to maintain data continuity and avoid re-engineering. Furthermore, data aggregated across different device types and manufacturers on the sendance-cloud platform could generate normative datasets for gait, pressure distribution, and device performance. These datasets could become valuable assets, potentially offered back to customers as benchmarking services or used to train predictive algorithms, creating a data moat that improves with each new device deployed. Early signs of this flywheel are suggested by the company's described process of iteratively developing prototypes with customers until product maturity is reached [Medizintechnik-Cluster].
Quantifying the size of the win requires looking at comparable infrastructure providers in adjacent digital health spaces. While no direct public peer exists, the valuation of companies that provide essential, regulated data layers in healthcare,such as those in continuous glucose monitoring or remote patient monitoring infrastructure,often hinges on recurring software revenue tied to hardware placement. If Sendance captured even a single-digit percentage of the €91 billion assistive and connected wearables market [F6S] through its platform-as-a-service model, the enterprise value could reach hundreds of millions of euros. A more concrete, scenario-based illustration: if the "Standardization in Orthopedic Prosthetics" path led to Sendance technology being embedded in 10% of the estimated several million prosthetic devices supplied annually in its core European and target markets, the resulting annual recurring platform revenue could support a valuation in line with other specialized medical device software companies. This is a scenario-based illustration of potential scale, not a financial forecast.
Data Accuracy: YELLOW -- The core market size figure (€91B) is cited by a single platform (F6S). The technology capabilities and business model are well-documented across multiple independent sources, including company presentations, industry reports, and partner publications.
Sources
PUBLIC
[Perplexity Sonar Pro Brief] Sendance company overview | https://www.perplexity.ai/search/Sendance-f418d04a-f52f-410a-861f-135e8f49a51d
[Advantage Austria] Sendance Smart Product-as-a-Service | https://www.advantageaustria.org/
[Tech2b] Sendance team and technology background | https://www.tech2b.com/
[OTWorld, 2026] Sendance product specifications and platform | https://www.otworld.com/
[LinkedIn, 2026] Sendance team profiles and company updates | https://at.linkedin.com/company/sendance-gmbh
[Crunchbase, Feb 2023] Sendance Pre Seed Round | https://www.crunchbase.com/funding_round/sendance-pre-seed--4a85f185
[Trending Topics, July 2023] Sendance seed funding from Garage Angels | https://www.trendingtopics.at/
[Northdata, 2024] Sendance state aid from FFG | https://www.northdata.com/
[Sendance Website] Sendance product and technology details | https://www.sendance.at
[Medizintechnik-Cluster] Sendance development and production process | https://www.medizintechnik-cluster.at/
[F6S] Sendance market opportunity | https://www.f6s.com/
[Dealroom.co, 2026] Sendance total capital raised | https://www.dealroom.co/
[DevelopmentAid] Sendance Horizon Europe experience | https://www.developmentaid.org/
[Vestbee] Sendance sensor technology applications | https://www.vestbee.com/insights/articles/sendance-secures-new-funding
[Grand View Research, 2024] Global wearable medical devices market | https://www.grandviewresearch.com/
Articles about Sendance
- Sendance's Soft Sensor Grids Turn Orthopedic Insoles Into Data Streams — The Austrian deep-tech spinout sells a 'Smart Product-as-a-Service' platform to device makers, aiming to capture a slice of the €91 billion assistive tech market.